drugset / Trial / NCT00500500

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

NCT00500500

Phase 2 Terminated 40 enrolled Ipsen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to measure the effect of EGb 761® versus placebo on the ratio of the isoform of the protein precursor of beta amyloid platelets, in patients with mild to moderate Alzheimer's disease.

Timeline

Start
2005-07
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM)

Indications